The IGNITE trial: Participant recruitment lessons prior to SARS-CoV-2

Full and diverse participant enrollment is critical to the success and generalizability of all large-scale Phase III trials. Recruitment of sufficient participants is among the most significant challenges for many studies. The novel SARS-CoV-2 coronavirus pandemic has further changed and challenged the landscape for clinical trial execution, including screening and randomization. The Investigating Gains in Neurocognition in an Intervention Trial of Exercise (IGNITE) study has been designed as the most comprehensive test of aerobic exercise effects on cognition and brain health. Here we assess recruitment into IGNITE prior to the increased infection rates in the United States, and examine new challenges and opportunities for recruitment with a goal of informing the remaining required recruitment as infection containment procedures are lifted. The results may assist the design and implementation of recruitment for future exercise studies, and outline opportunities for study design that are flexible in the face of emerging threats.

[1]  Oscar L. Lopez,et al.  Telephone Interview for Cognitive Status , 2009, Neuroepidemiology.

[2]  E. Vidoni,et al.  Novel recruitment models will drive Alzheimer's trial success , 2018, Alzheimer's & Dementia.

[3]  S. Hughes,et al.  ¡Ojo! What to expect in recruiting and retaining older Latinos in physical activity programs. , 2019, Translational behavioral medicine.

[4]  Miguel A L Nicolelis,et al.  Processing of tactile information by the hippocampus , 2007, Proceedings of the National Academy of Sciences.

[5]  G. Lamb.  Ageing , 1997, The Lancet.

[6]  P. Alam.  ‘W’ , 2021, Composites Engineering.

[7]  Tim Ramsay,et al.  Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials , 2015, Clinical trials.

[8]  C. Elliott.  Together We Make the Difference: National Strategy for Recruitment and Participation in Alzheimer's and Related Dementias Clinical Research. , 2020, Ethnicity & disease.

[9]  J. Cummings,et al.  Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes , 2017, Clinical and translational science.

[10]  S. Knight,et al.  Do clinical trials reflect reality? A systematic review of inclusion/exclusion criteria in trials of renal transplant immunosuppression , 2018, Transplant international : official journal of the European Society for Organ Transplantation.

[11]  Donald Silberberg,et al.  National Institutes of Health State-of-the-Science Conference Statement: Preventing Alzheimer Disease* and Cognitive Decline , 2010, Annals of Internal Medicine.

[12]  C. Vandelanotte,et al.  It’s not raining men: a mixed-methods study investigating methods of improving male recruitment to health behaviour research , 2019, BMC Public Health.

[13]  A. Newman,et al.  Preserving Clinical Trial Integrity During the Coronavirus Pandemic. , 2020, JAMA.

[14]  J. Watt,et al.  Representation of ethnic groups in dementia trials: systematic review and meta-analysis , 2018, Journal of the Neurological Sciences.

[15]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[16]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[17]  M. Weiner,et al.  The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions , 2016, Alzheimer's & Dementia.

[18]  J. Guralnik,et al.  Lifestyle interventions and independence for elders study: recruitment and baseline characteristics. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[19]  S. Studenski,et al.  Lifestyle Interventions and Independence for Elders Pilot Study: Recruitment and Baseline Characteristics , 2007, Journal of the American Geriatrics Society.

[20]  Chelsea M. Stillman,et al.  Investigating gains in neurocognition in an Intervention Trial of Exercise (IGNITE): Protocol. , 2019, Contemporary clinical trials.

[21]  K. Ferdinand,et al.  African-American COVID-19 Mortality , 2020, Journal of the American College of Cardiology.

[22]  E. Vidoni,et al.  Preliminary Efficacy of a Recruitment Educational Strategy on Alzheimer’s Disease Knowledge, Research Participation Attitudes, and Enrollment Among Hispanics , 2019, Hispanic health care international : the official journal of the National Association of Hispanic Nurses.

[23]  P. Alam,et al.  H , 1887, High Explosives, Propellants, Pyrotechnics.

[24]  Anna María Nápoles,et al.  COVID-19 and Racial/Ethnic Disparities. , 2020, JAMA.

[25]  D. Scharff,et al.  More than Tuskegee: Understanding Mistrust about Research Participation , 2010, Journal of health care for the poor and underserved.

[26]  Tsuyoshi Murata,et al.  {m , 1934, ACML.

[27]  P. Vemuri,et al.  Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences , 2014, Clinical epidemiology.

[28]  John B. Young,et al.  Improving recruitment of older people to clinical trials: use of the cohort multiple randomised controlled trial design. , 2015, Age and ageing.

[29]  A. Ludbrook,et al.  What works with men? A systematic review of health promoting interventions targeting men , 2008, BMC health services research.

[30]  H. Praag,et al.  Exercise and Hippocampal Memory Systems , 2019, Trends in Cognitive Sciences.

[31]  Catherine R. Harrison,et al.  Ageing, fitness and neurocognitive function , 1999, Nature.

[32]  E. McAuley,et al.  Exercise training increases size of hippocampus and improves memory , 2011, Proceedings of the National Academy of Sciences.

[33]  P. Alam.  ‘E’ , 2021, Composites Engineering: An A–Z Guide.

[34]  E. Vidoni,et al.  Feasibility of an Alzheimer's disease knowledge intervention in the Latino community , 2020, Ethnicity & health.

[35]  Marshal F. Folstein,et al.  The telephone interview for cognitive status , 1988 .

[36]  P. Tariot,et al.  Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform Network. , 2016, The journal of prevention of Alzheimer's disease.

[37]  C. Laurencin,et al.  The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities , 2020, Journal of Racial and Ethnic Health Disparities.